newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Announces Delisting from Nasdaq

Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company's failure to demonstrate compliance with Nasdaq Listing Rules